Progress and Works in Progress: Update on Flavivirus Vaccine Development
نویسندگان
چکیده
منابع مشابه
Update on progress in HIV vaccine development.
The 19th Conference on Retroviruses and Opportunistic Infections heralded the arrival of a new crop of potent, broadly neutralizing antibodies against HIV. This advance has given the entire vaccine field enormous hope that it will be possible one day to develop an antibody-based vaccine for HIV. However, substantial obstacles still exist in the induction of these antibodies by vaccination, give...
متن کاملProgress in HIV vaccine development.
Recent advances in HIV vaccine development include initiation of the first efficacy trials and substantial expansion of the preclinical pipeline. Several preclinical candidate vaccines have induced strong cellular immune responses and provided impressive protection against AIDS in non-human primate models; however, candidates that induce broadly neutralizing antibodies remain elusive.
متن کاملWorks In Progress
Wednesday, March 14 Research Poster Session I 11:30 a.m. – 1::00 p.m. (#43) Holly B. Fontenot, Melanie L. Kornides, Annie-Laurie McRee, Melissa B. Gilkey. Importance of a team recommendation approach on HPV vaccine uptake. (#167) Melanie L. Kornides, Holly B. Fontenot, Annie-Laurie McRee, Catherine A. Panozzo, Melissa B. Gilkey. Provider communication about HPV vaccination: Parents' satisfactio...
متن کاملProgress and challenges in TB vaccine development
The Bacille Calmette Guerin (BCG) vaccine can provide decades of protection against tuberculosis (TB) disease, and although imperfect, BCG is proof that vaccine mediated protection against TB is a possibility. A new TB vaccine is, therefore, an inevitability; the question is how long will it take us to get there? We have made substantial progress in the development of vaccine platforms, in the ...
متن کاملSchistosomiasis vaccine development: progress and prospects.
The undisputed, worldwide success of chemotherapy notwithstanding, schistosomiasis continues to defy control efforts in as much rapid reinfection demands repeated treatment, sometimes as often as once a year. There is thus a need for a complementary tool with effect for the longer term, notably a vaccine. International efforts in this direction have been ongoing for several decades but, until t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Therapeutics
سال: 2017
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2017.07.001